​Latest Elsevier Gender Equality Study Reveals 20 Years Of Progress, But Challenges Remain For Women in Research And Innovation​​

Elsevier, a global leader in scientific information and analytics with a long-standing commitment to advancing inclusion in research and health, has released its latest report analyzing gender equality in research. Progress Towards Gender Equality in Research & Innovation – 2024 Review examines inclusion and diversity in career cohorts across intersecting disciplines and geographies, tracking multiple indicators over 20 years. It reveals progress, with women now representing 41% of researchers globally, but also that serious challenges persist in gender equality in research and innovation. 

Notably, at the current pace of change, equality remains unacceptably far away; for example, although women’s representation in mathematics, engineering and computer science is increasing, it is not projected to reach parity with men’s until 2052. And, while grant funding for women is rising (from 29% in 2009 to 37% in 2022), translation of research into innovation through patent applications – which serve as a proxy for understanding involvement in the full value chain of research - is much lower for women researchers. This is despite women’s strong performance in disciplines that relate to solving some of the biggest challenges the world faces, as expressed in the UN Sustainable Development Goals. 

The Report​​ provides a substantial evidence base for academic leaders, funders, and policymakers to take data-led action on gender equality in research and innovation; key findings include:  

• Women have made gains in the last two decades – as of 2022, they represent 41% (compared to 28% in 2001) of all active researchers globally, with strong representation in Health Sciences. However, gender diversity hasn’t progressed equally in all fields, for example in the physical sciences women represent just 33% of researchers. 

• Women’s participation in the research workforce differs substantially by country/region. In Portugal, Spain, Italy, Argentina and Brazil, around half of active researchers are women, with around 40% in the USA and UK. However, women make up 33% of active researchers in India, now the world’s third largest research producing country; 30% in Egypt; and less than a quarter (22%) of active researchers in Japan.  

• The average share of women among grant awardees increased globally from 29% in 2009 to 37% in 2022. The largest increases were for the Netherlands (+19 percentage points), Denmark (+13), the United Kingdom (+12), France (+10), Canada (+10), and Portugal (+8).  

• Women comprise the majority of active researchers working on some UN SDG research areas, including education (SDG 4), gender equality (SDG 5), reduce inequalities (SDG 10) and peace and justice (SDG 16). For 10 of the 17 SDGs, proportionally slightly more women engage in more multidisciplinary research than men. Multidisciplinary research, in which researchers from diverse disciplinary backgrounds collaborate, is considered important to solving complex global challenges.  

• Women’s progress is especially marked when assessed using indicators around societal impact, with their research more likely than men’s to be cited in policy documents and media.  

The report offers five recommended areas of action for the research and innovation communities: 

• Accelerate commitments and actions towards greater gender equality in research. 

• Stop the decline in participation with rising seniority by prioritizing the retention of early-career women researchers into mid and advanced career stages. 

• Develop incentive structures to help women play an equal part in the full research and innovation value chain, including patents. 

• Apply a broad range of indicators to measure research effectiveness, including societal and policy impact. 

• Continue to collect and report inclusion and diversity data to monitor progress, identify gaps, evaluate policies, and drive accountability. 

 Commenting on the report, Mirit Eldor, Managing Director, Life Sciences Solutions at Elsevier and Secretary of its Inclusion and Diversity Independent Advisory Board, said: “With guidance from our Inclusion and Diversity Advisory Board, we have shaped this latest Gender Report to illuminate progress, ongoing disparities and pathways towards a more equitable research ecosystem.  The report also offers the research community insights that can help evolve how research excellence is evaluated. We can now better understand the impact of women’s research in addressing the most serious challenges our world faces today.”  

Dr. Hannah Valantine, Professor of Medicine, Stanford University and member of Elsevier’s Inclusion and Diversity Advisory Board, said: “I was just so taken aback by the Gender Report's scope, depth, breadth, thoughtfulness, and potential for real impact. It can lead to genuine culture change within institutions and funding agencies to in turn benefit individual researchers of all genders throughout their careers.”  

In an era where researchers are increasingly expected to help tackle the world’s most complex and important problems, especially as the 2030 deadline for the UN SDGs gets closer, the Report provides valuable intersectional insight into women’s contribution to the global research and innovation ecosystem, the need for traditional academic evaluation metrics to evolve, and the continuing imperative for greater inclusiveness in the research and innovation workforce.    

Notes to Editors 

To explore the findings of Elsevier's report, summary infographics, methodology, accompanying data dashboard, and previous gender reports, visit https://www.elsevier.com/insights/gender-and-diversity-in-research.

エルゼビアについて エルゼビアは、科学情報と分析を牽引するグローバル企業として、研究者や医療従事者が社会の利益のために科学を進歩させ、医療成果を向上させることを支援しています。我々は信頼できるエビデンスベースのコンテンツと高度なAI対応デジタルテクノロジーに基づくソリューションにより、インサイトと重要な意思決定を促進することでこれを実現しています。

エルゼビアは、140 年以上にわたり研究および医療コミュニティの活動を支援してきました。全世界で 2,500 人以上の技術者を含む 9,500 人の従業員がおり、重要な職務における研究者や、図書館員、アカデミックリーダー、資金提供者、政府機関、R&D 関連企業、医師、看護師、将来の医療従事者や教育者を支援することに従事してきました。2,900 誌以上の科学ジャーナルと代表的な参考文献には、Cell Press、The Lancet、Gray's Anatomy など、各分野の主要なタイトルを含みます。 エルゼビア・ファウンデーション 新しいタブ／ウィンドウで開くと共に、開発途上国および世界中の科学、研究、医療分野におけるインクルージョン＆ダイバーシティ 新しいタブ／ウィンドウで開くを推進するため、支援コミュニティと連携して活動しています。 エルゼビアは、プロフェッショナルおよびビジネス顧客向けの情報に基づく分析および意思決定ツールのグローバルプロバイダーである RELX 新しいタブ／ウィンドウで開くグループの一部です。業務内容やデジタルソリューション、コンテンツ詳細については、 www.elsevier.com/ja-jpをご参照ください。